Clinical sites get their own industry group

- Last updated on GMT

Related tags: Clinical research sites, Clinical trial

Research sites get industry group
A new trade organisation intended to give clinical research sites a voice was launched at industry event earlier this week.

The Society for Clinical Research Sites (SCRS) - which was unveiled during the 7th Annual Site Solutions Summit - was founded as a trade organization to represent the voice of clinical research sites within the clinical research sector.

Co-founder Christine Pierre aims to provide clinical sites with resources, mentoring and new ideas through a membership organization dedicated to providing sites both a voice and community.

"Sites have a major role to play in the clinical trials process, and for too long, they have been the silent partner in the research enterprise, but they will no longer be passive participants. Now is the time for sites to become active partners in the dialogues and solutions through the voice of SCRS​."

The initiative is supported by Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, who suggested that SCRS can have a positive impact on pharmaceutical development.

"This is a significant advancement for the clinical research community​" Woodcock said, adding that "having a voice for clinical research sites will contribute to the development of innovative clinical studies to gain important information more quickly, and, ultimately, to bring promising drugs to patients in need​."

The aims of the new organisation are as follows:

- To foster collegiality and appropriate sharing of information and insights.

- Advocate by vocalizing and disseminating the clinical research sites' positions on critical issues and educating other stakeholders regarding those positions.

- Promote opportunities for the investigative site community to connect and learn from fellow sites and other critical stakeholders.

- To educate and mentor sites to ensure success and the continuation of a legacy of excellence.

Related topics: Clinical Development, Phase I-II

Related news

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Related suppliers

Follow us


View more